We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+12.78%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$506M
AUM Growth
-$51.4M
(-9.2%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
739
New
70
Increased
160
Reduced
252
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$11.6M |
| 2 |
iShares MSCI Philippines ETF
EPHE
|
+$9.69M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$6.25M |
| 4 |
Eaton
ETN
|
+$4.48M |
| 5 |
Gilead Sciences
GILD
|
+$4.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Thailand ETF
THD
|
+$7.93M |
| 2 |
iShares MSCI Chile ETF
ECH
|
+$6.49M |
| 3 |
Boeing
BA
|
+$6.44M |
| 4 |
Linde
LIN
|
+$6.16M |
| 5 |
Chemours
CC
|
+$4.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 9.77% |
| 2 | Energy | 7.83% |
| 3 | Technology | 7.77% |
| 4 | Financials | 7.67% |
| 5 | Consumer Discretionary | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Illumina
ILMN
$29B
| $92.5K | 0.02% |
306
+172
| +128% | +$50.2K |
|
302
FMC
FMC
$1.4B
| $91.9K | 0.02% |
1,197
-657
| -35% | -$48.2K |
|
303
Stryker
SYK
$129B
| $91.2K | 0.02% |
462
+211
| +84% | +$38K |
|
304
Ligand Pharmaceuticals
LGND
$6.03B
| $90.5K | 0.02% |
1,154
+734
| +175% | +$55.6K |
|
305
PUT
Itaú Unibanco
ITUB
$92B
| $90K | 0.02% |
4,123
-7,559
| -65% | -$53.5K |
|
306
Simon Property Group
SPG
$74.8B
| $87.8K | 0.02% |
482
+459
| +1,996% | +$81.6K |
|
307
Marriott Vacations Worldwide
VAC
$3.32B
| $87.6K | 0.02% |
937
+403
| +75% | +$36.2K |
|
308
Thor Industries
THO
$4.09B
| $87.5K | 0.02% |
1,403
+767
| +121% | +$48.6K |
|
|
WMGI
309
DELISTED
Wright Medical Group Inc
WMGI
| $87.3K | 0.02% |
2,777
+1,222
| +79% | +$37.1K |
|
|
EPZM
310
DELISTED
Epizyme, Inc
EPZM
| $84.2K | 0.02% |
+6,800
| New | +$76K |
|
311
Royal Caribbean
RCL
$79.3B
| $84.2K | 0.02% |
735
+338
| +85% | +$38.4K |
|
312
Tilray
TLRY
$486M
| $83.9K | 0.02% |
128
-839
| -87% | -$640K |
|
313
LCI Industries
LCII
$2.53B
| $82.9K | 0.02% |
1,079
+521
| +93% | +$41.2K |
|
314
Hartford Financial Services
HIG
$38.6B
| $81.2K | 0.02% |
1,634
+82
| +5% | +$3.89K |
|
315
PUT
Vale
VALE
$62.3B
| $80.5K | 0.02% |
+1,000
| New | +$12.9K |
|
316
BioMarin Pharmaceuticals
BMRN
$11.7B
| $79.7K | 0.02% |
897
+430
| +92% | +$39.9K |
|
|
SPPI
317
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $79.5K | 0.02% |
7,440
+4,414
| +146% | +$47.3K |
|
318
Orthofix Medical
OFIX
$475M
| $78.7K | 0.02% |
1,395
+672
| +93% | +$37.7K |
|
319
Encompass Health
EHC
$11.3B
| $74.4K | 0.01% |
1,601
+876
| +121% | +$44.4K |
|
320
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
| $71.4K | 0.01% |
600
-6,000
| -91% | -$695K |
|
321
JD.com
JD
$41.1B
| $70K | 0.01% |
2,321
-1,279
| -36% | -$32.5K |
|
322
Wheaton Precious Metals
WPM
$50.6B
| $69.2K | 0.01% |
2,905
-74,978
| -96% | -$1.6M |
|
|
SCHW
323
Charles Schwab
SCHW
$180B
| $63.9K | 0.01% |
+1,495
| New | +$67.5K |
|
324
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.39B
| $63.9K | 0.01% |
1,505
-539
| -26% | -$22.2K |
|
325
Oxford Square Capital
OXSQ
$155M
| $63.2K | 0.01% |
9,733
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2019 Portfolio in Review
As of Q1 2019, Exane Derivatives held 739 positions worth $506M, down 9.2% from $557M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Exane Derivatives withdrew a net $43.2M in Q1 2019, closing 106 positions and reducing 252 holdings. Its most notable exit was Boeing, an estimated $6.44M position sold in full.
By sector, the portfolio is most concentrated in Materials at 9.8% of assets, down from 11% a quarter earlier, followed by Energy and Technology.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $11.2M.
- Exane Derivatives's largest Q1 2019 buy was UBS Group: 919,334 shares worth $11.2M.
- Exane Derivatives added most to iShares MSCI Philippines ETF in Q1 2019, an estimated $9.69M increase.
- Exane Derivatives's biggest Q1 2019 reduction was iShares MSCI Thailand ETF, cutting an estimated $7.93M.
- Exane Derivatives fully exited Boeing in Q1 2019, selling an estimated $6.44M.
- Exane Derivatives's ten largest holdings make up 28% of its $506M portfolio in Q1 2019.
- Exane Derivatives opened 70 new positions and closed 106 in Q1 2019.
- Exane Derivatives's portfolio value fell 9.2% quarter-over-quarter to $506M.
Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.